Citations 1
Change in 21-gene recurrence score (RS) (Oncotype DX) after exposure to neoadjuvant endocrine therapy.
Mi, Lanyu , Anderson, Karen S. , Pockaj, Barbara A. , Gray, Richard J. , Dixon, Leslie E, Martinez, Erika D., Singh, Charanjit , Northfelt, Donald W. , Hilal, Talal
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e12650-e12650
